- New-born Screening
- Diagnostic Testing
- Prenatal Testing
- Carrier Testing
- Predictive and Pre-Symptomatic Testing
Genetic Testing Market size was valued at USD 18.6 billion in 2023 and is poised to grow at a CAGR of 11.9% from 2024-2030. The DNA, a chemical databank that conveys commands for the body's utilities, is examined during genetic testing. Changes or mutations in the genes that may cause illness or disease can be discovered by genetic testing. The rise in the incidence of genetic diseases and the growing demand for identifying genetic disorders are two major factors driving growth in the global genetic testing market. Chronic diseases are primarily caused by genetic abnormalities. Genetic testing makes available technology that aids in the early discovery of various genetic illnesses, as well as treatment and prevention.
Genetic testing is widely utilized for a variety of applications. In 2015, there were around 15.1 million new cancer cases worldwide, with more than half of these instances coming from economically developing countries such as India, China, and others. Prenatal genetic testing is a procedure that aids in the detection of genetic diseases in the fetus. Mutations in a person's genes or chromosomes are the most common cause of genetic disorders. Aneuploidy, trisomy, monosomy, and a variety of other hereditary illnesses are among the most common genetic abnormalities. Pharmacogenomics is the study of congenital changes in human genes that influence a person's pharmacological response. Pharmacogenomics is a field that combines pharmaceutical and genetic sciences. As a result, it is the science of customizing a medicine depending on a person's genetic composition. A predisposition is an increase in the likelihood of a disease developing as a result of a person's genetic composition. A genetic predisposition is caused by specific genetic abnormalities that are passed down from one parent to the next.
Global Genetic Testing Market Summary
Study Period
2024-2030
Base Year
2023
CAGR
11.9%
Largest Market
North America
Fastest Growing Market
Europe
Genetic Testing Market Dynamics
Technological advancements in the genetic testing enhances the revenue of genetic testing market over the forecast years. Advanced genetic testing technology enhances the precision of analysis of clinical biomarkers. Moreover, innovations in the genetic tests offer efficient and safer technique in the disease detection that may reduce the miscarriage during the early stage of pregnancy. Furthermore, surge in adoption of genetic testing among the population, favorable reimbursement policies, and presence of skilled professionals are bolster the genetic testing market over the forecast timeframe. Moreover, rise in adoption for the personalized medicine, increase in demand for early stage disease diagnosis, surge in adoption of genetic testing in developed and developing countries, and sophisticated healthcare infrastructure are the major factors that are driving the growth of the genetic testing market.
North-America Got Significant Share
Genetic Testing Market Regional Analysis
North America accounted for larger revenue share in global market with significant CAGR. Increase in prevalence of genetic disorders such as cancer, diabetes, and other chronic diseases, rise in demand for personalized medicine, and grow in R&D for the development of advanced tests by the market players are propel the genetic testing market in the North America region. Europe market projected to grow at significant rate owing to increase in adoption of advanced genetic tests, rise in health awareness among the population, increase in the incidence of genetic disorders are expected to enhance the market.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Global Genetic Testing Market Segmentation
By Test Type
By Technology
- Molecular Testing
- Cytogenetic Testing
- Biochemical Testing
By Application
- Thalassemia
- Sickle Cell Anemia
- Cancer
- Cystic Fibrosis
- Alzheimer's Disease
- Huntington's Disease
- Others
By End User
- Hospitals
- Clinics
- Diagnostic Centers
Frequently Asked Questions
The genetic testing market size was valued at USD 18.6 billion in 2023
The major key players operating in the genetic testing market are 10X Genomics, Inc., Quest Diagnostics Incorporated, QIAGEN N.V., Myriad Genetics Inc., Bio-Rad Laboratories Inc. Hoffmann-La Roche Ltd, Eurofins Scientific, Blueprint Genetics, Illumina Inc., BGI Genomics, PerkinElmer Inc., Abbott Laboratories, Thermo Fisher Scientific Inc.
North America is the fastest-growing region for genetic testing market
| 1. Executive Summary |
| 2. Global Genetic Testing Market Introduction |
| 2.1. Global Genetic Testing Market - Taxonomy |
| 2.2. Global Genetic Testing Market -Definitions |
| 2.2.1. By Testing Type |
| 2.2.2. By Technology |
| 2.2.3. By Sample Type |
| 2.2.4. By Indication |
| 2.2.5. By Region |
| 3. Global Genetic Testing Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Genetic Testing Market Dynamic Factors - Impact Analysis |
| 3.6. Global Genetic Testing Market - Competition Landscape |
| 4. Global Genetic Testing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Genetic Testing Market, By Testing Type, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.1. Predictive & Presymptomatic Testing |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Carrier Testing |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Prenatal & Newborn Testing |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Diagnostic Testing |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Pharmacogenomic Testing |
| 5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Others |
| 5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 6. Global Genetic Testing Market, By Technology, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.1. Cytogenetic Testing |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Biochemical Testing |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Molecular Testing |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7. Global Genetic Testing Market, By Sample Type, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.1. Blood |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Saliva |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Hair |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Others |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8. Global Genetic Testing Market, By Indication, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.1. Cancer |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Cardiovascular Diseases |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Neurological Diseases |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Hematological Diseases |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Rare Diseases |
| 8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 8.6. Others |
| 8.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 8.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.6.3. Market Opportunity Analysis |
| 9. Global Genetic Testing Market Forecast, By Region, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia-Pacific |
| 9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Latin America |
| 9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Middle East and Africa |
| 9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 9.6. Global Genetic Testing Market - Opportunity Analysis Index, By Testing Type, Technology, Sample Type, Indication, and Region, 2024 - 2030 |
| 10. North America Genetic Testing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 10.1. Testing Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Predictive & Presymptomatic Testing |
| 10.1.2. Carrier Testing |
| 10.1.3. Prenatal & Newborn Testing |
| 10.1.4. Diagnostic Testing |
| 10.1.5. Pharmacogenomic Testing |
| 10.1.6. Others |
| 10.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1. Cytogenetic Testing |
| 10.2.2. Biochemical Testing |
| 10.2.3. Molecular Testing |
| 10.3. Sample Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.3.1. Blood |
| 10.3.2. Saliva |
| 10.3.3. Hair |
| 10.3.4. Others |
| 10.4. Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.4.1. Cancer |
| 10.4.2. Cardiovascular Diseases |
| 10.4.3. Neurological Diseases |
| 10.4.4. Hematological Diseases |
| 10.4.5. Rare Diseases |
| 10.4.6. Others |
| 10.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.5.1. USA |
| 10.5.2. Canada |
| 10.6. North America Genetic Testing Market - Opportunity Analysis Index, By Testing Type, Technology, Sample Type, Indication, and Country, 2024 - 2030 |
| 10.7. North America Genetic Testing Market Dynamics - Trends |
| 11. Europe Genetic Testing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 11.1. Testing Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Predictive & Presymptomatic Testing |
| 11.1.2. Carrier Testing |
| 11.1.3. Prenatal & Newborn Testing |
| 11.1.4. Diagnostic Testing |
| 11.1.5. Pharmacogenomic Testing |
| 11.1.6. Others |
| 11.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1. Cytogenetic Testing |
| 11.2.2. Biochemical Testing |
| 11.2.3. Molecular Testing |
| 11.3. Sample Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.3.1. Blood |
| 11.3.2. Saliva |
| 11.3.3. Hair |
| 11.3.4. Others |
| 11.4. Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.4.1. Cancer |
| 11.4.2. Cardiovascular Diseases |
| 11.4.3. Neurological Diseases |
| 11.4.4. Hematological Diseases |
| 11.4.5. Rare Diseases |
| 11.4.6. Others |
| 11.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.5.1. Germany |
| 11.5.2. UK |
| 11.5.3. France |
| 11.5.4. Spain |
| 11.5.5. Italy |
| 11.5.6. Russia |
| 11.5.7. Rest of Europe |
| 11.6. Europe Genetic Testing Market - Opportunity Analysis Index, By Testing Type, Technology, Sample Type, Indication, and Country, 2024 - 2030 |
| 11.7. Europe Genetic Testing Market Dynamics - Trends |
| 12. Asia-Pacific Genetic Testing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 12.1. Testing Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Predictive & Presymptomatic Testing |
| 12.1.2. Carrier Testing |
| 12.1.3. Prenatal & Newborn Testing |
| 12.1.4. Diagnostic Testing |
| 12.1.5. Pharmacogenomic Testing |
| 12.1.6. Others |
| 12.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1. Cytogenetic Testing |
| 12.2.2. Biochemical Testing |
| 12.2.3. Molecular Testing |
| 12.3. Sample Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.3.1. Blood |
| 12.3.2. Saliva |
| 12.3.3. Hair |
| 12.3.4. Others |
| 12.4. Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.4.1. Cancer |
| 12.4.2. Cardiovascular Diseases |
| 12.4.3. Neurological Diseases |
| 12.4.4. Hematological Diseases |
| 12.4.5. Rare Diseases |
| 12.4.6. Others |
| 12.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.5.1. China |
| 12.5.2. India |
| 12.5.3. Japan |
| 12.5.4. ASEAN |
| 12.5.5. Australia & New Zealand |
| 12.5.6. Rest of Asia-Pacific |
| 12.6. Asia-Pacific Genetic Testing Market - Opportunity Analysis Index, By Testing Type, Technology, Sample Type, Indication, and Country, 2024 - 2030 |
| 12.7. Asia-Pacific Genetic Testing Market Dynamics - Trends |
| 13. Latin America Genetic Testing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 13.1. Testing Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1. Predictive & Presymptomatic Testing |
| 13.1.2. Carrier Testing |
| 13.1.3. Prenatal & Newborn Testing |
| 13.1.4. Diagnostic Testing |
| 13.1.5. Pharmacogenomic Testing |
| 13.1.6. Others |
| 13.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1. Cytogenetic Testing |
| 13.2.2. Biochemical Testing |
| 13.2.3. Molecular Testing |
| 13.3. Sample Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.3.1. Blood |
| 13.3.2. Saliva |
| 13.3.3. Hair |
| 13.3.4. Others |
| 13.4. Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.4.1. Cancer |
| 13.4.2. Cardiovascular Diseases |
| 13.4.3. Neurological Diseases |
| 13.4.4. Hematological Diseases |
| 13.4.5. Rare Diseases |
| 13.4.6. Others |
| 13.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 13.5.1. Brazil |
| 13.5.2. Mexico |
| 13.5.3. Rest of Latin America |
| 13.6. Latin America Genetic Testing Market - Opportunity Analysis Index, By Testing Type, Technology, Sample Type, Indication, and Country, 2024 - 2030 |
| 13.7. Latin America Genetic Testing Market Dynamics - Trends |
| 14. Middle East and Africa Genetic Testing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
| 14.1. Testing Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1. Predictive & Presymptomatic Testing |
| 14.1.2. Carrier Testing |
| 14.1.3. Prenatal & Newborn Testing |
| 14.1.4. Diagnostic Testing |
| 14.1.5. Pharmacogenomic Testing |
| 14.1.6. Others |
| 14.2. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.2.1. Cytogenetic Testing |
| 14.2.2. Biochemical Testing |
| 14.2.3. Molecular Testing |
| 14.3. Sample Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.3.1. Blood |
| 14.3.2. Saliva |
| 14.3.3. Hair |
| 14.3.4. Others |
| 14.4. Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.4.1. Cancer |
| 14.4.2. Cardiovascular Diseases |
| 14.4.3. Neurological Diseases |
| 14.4.4. Hematological Diseases |
| 14.4.5. Rare Diseases |
| 14.4.6. Others |
| 14.5. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 14.5.1. Gulf Cooperation Council (GCC) Countries |
| 14.5.2. South Africa |
| 14.5.3. Rest of MEA |
| 14.6. MEA Genetic Testing Market - Opportunity Analysis Index, By Testing Type, Technology, Sample Type, Indication, and Country, 2024 - 2030 |
| 14.7. MEA Genetic Testing Market Dynamics - Trends |
| 15. Competition Landscape |
| 15.1. Strategic Dashboard of Top Market Players |
| 15.2. Company Profiles (Introduction, Financial Analysis, Key Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 15.2.1. 10X Genomics, Inc. |
| 15.2.2. Quest Diagnostics Incorporated |
| 15.2.3. QIAGEN N.V. |
| 15.2.4. Myriad Genetics Inc. |
| 15.2.5. Bio-Rad Laboratories Inc. |
| 15.2.6. F. Hoffmann-La Roche Ltd |
| 15.2.7. Eurofins Scientific |
| 15.2.8. Blueprint Genetics |
| 15.2.9. Illumina Inc. |
| 15.2.10. BGI Genomics |
| 15.2.11. PerkinElmer Inc. |
| 15.2.12. Abbott Laboratories |
| 15.2.13. Thermo Fisher Scientific Inc. |
| 16. Research Methodology |
| 17. Key Assumptions and Acronyms |
- Qiagen N.V.
- PerkinElmer, Inc.
- Applied Biosystems
- Biocartis S.A.
- Genentech, Inc.
- Hoffmann La Roche Ltd.
- Quest Diagnostics
- Illumina, Inc.
- Bayer Diagnostics
- Konica Minolta, Inc.
- Abbott Laboratories
- Myriad Genetics